SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
188 hedge funds and large institutions have $645M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 52 increasing their positions, 56 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
+10
Holders Change %
+5.62%
% of All Funds
4.27%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
52
Increased
52
Reduced
56
Closed
41
Calls
$11.5M
Puts
$8.23M
Net Calls
+$3.3M
Net Calls Change
+$2.42M
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
+$28.7M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$26.8M |
| 3 |
JPMorgan Chase & Co
New York
|
+$17.6M |
| 4 |
PCM
Prelude Capital Management
New York
|
+$12M |
| 5 |
Renaissance Technologies
New York
|
+$11.7M |
Top Sellers
| 1 |
KAM
Krensavage Asset Management
New York
|
-$27.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$22M |
| 3 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$14.9M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$10.5M |
| 5 |
Goldman Sachs
New York
|
-$8.85M |
